LakeShore Biopharma Co Ltd (LSB)
0.8373
+0.06
(+7.59%)
USD |
NASDAQ |
Sep 27, 16:00
0.862
+0.02
(+2.95%)
After-Hours: 20:00
LakeShore Biopharma Cash from Financing (Quarterly): 6.199M for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 6.199M |
Date | Value |
---|---|
September 30, 2022 | 7.577M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
6.199M
Minimum
Sep 2023
7.577M
Maximum
Sep 2022
6.888M
Average
6.888M
Median
Cash from Financing (Quarterly) Benchmarks
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -20.15M |
Cash from Investing (Quarterly) | -3.237M |